Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour
This study has been completed.
Study NCT00346840   Information provided by Cytokine PharmaSciences
First Received: June 29, 2006   Last Updated: December 5, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Labor Induction
Cervical Ripening
Interventions listed in this trial
Misoprostol vaginal insert 25 mcg
Misoprostol vaginal insert 50 mcg
Misoprostol vaginal insert 100 mcg
Misoprostol vaginal insert 200 mcg
Additional drug interventions recognized in this trial
Misoprostol
More general drug interventions related to this trial
Abortifacient Agents
Abortifacient Agents, Nonsteroidal
Anti-Ulcer Agents
Gastrointestinal Agents
Oxytocics
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Cytokine PharmaSciences


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services